{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T05:59:17Z","timestamp":1707112757379},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1993,1]]},"DOI":"10.1007\/bf01844200","type":"journal-article","created":{"date-parts":[[2005,7,2]],"date-time":"2005-07-02T19:14:09Z","timestamp":1120331649000},"page":"S25-S28","source":"Crossref","is-referenced-by-count":9,"title":["Deflazacort in the treatment of haematologic disorders"],"prefix":"10.1007","volume":"45","author":[{"given":"M.","family":"Gobbi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Scudeletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01844200_CR1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1600-065X.1982.tb00431.x","volume":"65","author":"TR Cupp","year":"1982","unstructured":"Cupp TR, Fauci AS (1982) Corticosteroid-mediated immunoregulation in man Immunol Rev 65: 133","journal-title":"Immunol Rev"},{"key":"BF01844200_CR2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1056\/NEJM198702123160705","volume":"316","author":"B Beutler","year":"1987","unstructured":"Beutler B, Cerami A (1987) Cachectin: more than a tumor necrosis factor. N Engl J Med 316: 379\u2013385","journal-title":"N Engl J Med"},{"key":"BF01844200_CR3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev.me.37.020186.001133","volume":"37","author":"CA Dinarello","year":"1986","unstructured":"Dinarello CA, Mier JW (1986) Interleukins. Annu Rev Med 37: 173","journal-title":"Annu Rev Med"},{"key":"BF01844200_CR4","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.4049\/jimmunol.140.6.1895","volume":"140","author":"W Lew","year":"1988","unstructured":"Lew W, Oppenheim JJ, Matsushima K (1988) Analysis of the suppression of IL-1 a and IL-1 B production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone. J Immunol 140: 1895\u20131901","journal-title":"J Immunol"},{"key":"BF01844200_CR5","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1172\/JCI112427","volume":"77","author":"JS Goodwin","year":"1986","unstructured":"Goodwin JS, Artluru D, Sierakowski S, Lianos EA (1986) Mechanism of action of glucocorticoids Inhibition of T cell proliferation and interleukin 2 production of hydrocortisone is reversed by leukotriene B. J Clin Invest 77: 1244\u20131249","journal-title":"J Clin Invest"},{"key":"BF01844200_CR6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0162-3109(86)90032-9","volume":"11","author":"G Gatti","year":"1986","unstructured":"Gatti G, Cavallo R, Sartori M, Marinone C, Angeli A (1986) Cortisol at physiological concentrations and prostaglandin E2 are active inhibitors of human natural killer cell activity. Immunopharmacology 11: 119\u2013125","journal-title":"Immunopharmacology"},{"key":"BF01844200_CR7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1749-6632.1990.tb34310.x","volume":"595","author":"M Scudeletti","year":"1990","unstructured":"Scudeletti M, Castagnetta L, Imbimbo B, Puppo F, Pierri I, Indiveri F (1990) New glucocorticoids Mechanisms of immunological activity at the cellular level and the clinical setting. Ann NY Acad Sci vol 595: 368\u2013382","journal-title":"Ann NY Acad Sci vol"},{"key":"BF01844200_CR8","first-page":"1166","volume-title":"Vasculitis in arthritis and allied conditions: a textbook of rheumatology","author":"AS Fauci","year":"1989","unstructured":"Fauci AS, Leavitt RY (1989) Vasculitis in arthritis and allied conditions: a textbook of rheumatology 11 th edn, McCarty, DJ (ed) Lea & Febiger, Philadelphia, pp 1166","edition":"11 th edn"},{"key":"BF01844200_CR9","first-page":"54","volume":"24","author":"AS Fauci","year":"1986","unstructured":"Fauci AS (1986) Mechanisms of corticosteroid action on lymphocyte subpopulations II. Differential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function. Clin Exp Immunol 24: 54\u201362","journal-title":"Clin Exp Immunol"},{"key":"BF01844200_CR10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1021\/jm00317a009","volume":"10","author":"GG Nathansohn","year":"1979","unstructured":"Nathansohn GG, Winters G, Testa E (1979) Steroid possessing nitrogen III. Synthesis of new highly active corticoids (17 alpha, 16 alpha-d) oxazoline steroids. J Med Chem 10: 799\u2013786","journal-title":"J Med Chem"},{"key":"BF01844200_CR11","first-page":"69","volume":"26","author":"G Buniva","year":"1979","unstructured":"Buniva G, Dubini A, Sassella D (1979) Human biossay of corticotropin suppressing eosinopenic and hyperglycaemic potencies of deflazacort and prednisone. Curr Ther Res 26: 69\u201374","journal-title":"Curr Ther Res"},{"key":"BF01844200_CR12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF02405325","volume":"36","author":"CB Gennari","year":"1984","unstructured":"Gennari CB, Imbimbo B, Montagnani M (1984) Effects of short and mediumterm treatments with prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans. Calcif Tissue Int 36: 245\u2013252","journal-title":"Calcif Tissue Int"},{"key":"BF01844200_CR13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF00542555","volume":"22","author":"G Pagano","year":"1982","unstructured":"Pagano G, Lombardi A, Feraris GM, Imbimbo B, Cavallo Perin P (1982) Acute effect of prednisone and deflazacort on glucose tolerance in pediatric subjects Eur J Clin Pharmacol 22: 469\u2013471","journal-title":"Eur J Clin Pharmacol"},{"key":"BF01844200_CR14","first-page":"406","volume":"II","author":"R Gerard-Marchand","year":"1974","unstructured":"Gerard-Marchand R, Hamlin L, Lennert K, Rilke F, Stansfeld AG, Van Unnik JAM (1974) Classification of non Hodgkin's lymphomas. Lancet II: 406\u2013408","journal-title":"Lancet"},{"key":"BF01844200_CR15","first-page":"1860","volume":"31","author":"PP Carbone","year":"1971","unstructured":"Carbone PP, Kaplan HS, Musshoff K, Smithers WW, Tubiana M (1971) Report of the committee on Hodgkin's disease staging classification. Cancer Res 31: 1860\u20131861","journal-title":"Cancer Res"},{"key":"BF01844200_CR16","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.1986.4.10.1470","volume":"4","author":"G J Gallagher","year":"1986","unstructured":"Gallagher G J, Gregory WM, Jones AE, Stanfeld AG, Richards MA, Dhaliwal HS, Malpas JS, Lister A (1986) Follicular lymphoma: prospectic factors for response and survival. J Clin Oncol 4: 1470\u20131480","journal-title":"J Clin Oncol"},{"key":"BF01844200_CR17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0002-9343(80)90016-9","volume":"69","author":"SM Fino De","year":"1980","unstructured":"De Fino SM, Lachant LM, Kirschner JJ, Gottlieb AS (1980) Adult idiopathic thrombocytopenic purpura. Clinical findings and response to therapy. Ann J Med 69: 430\u2013442","journal-title":"Ann J Med"},{"key":"BF01844200_CR18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2141.1991.tb04513.x","volume":"79","author":"A Manoharan","year":"1991","unstructured":"Manoharan A (1991) Treatment of refractory idiopathic trombocytopenic purpura in adults. Br J Haematol 79: 143\u2013147","journal-title":"Br J Haematol"},{"key":"BF01844200_CR19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000205684","volume":"79","author":"A Monteverde","year":"1988","unstructured":"Monteverde A, Rivano MT, Allegra GC, Monteverde AI, Zigrossi P, Baglioni P, Gobbi M, Falini B, Bordin G, Pileri S (1988) Essential mixed crioglobulinemia. Type II: a manifestation of a low grade malignant lymphoma? Acta Haemat 79: 20\u201325","journal-title":"Acta Haemat"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01844200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01844200\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01844200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T17:14:18Z","timestamp":1683134058000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01844200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":19,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["BF01844200"],"URL":"https:\/\/doi.org\/10.1007\/bf01844200","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]}}}